Supplementary Table 1 from An Open-Label, Dose–Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma
Year: 2023
Type: supplementary-materials
Abstract: Summary of TEAE by system organ class (SOC) grade greater than or equal to 3. Number of patients (%)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362400742